US regulators review Moderna application
5h
U.S. regulators reversed course and agreed to review Moderna’s mRNA influenza vaccine application after earlier moves to block the company’s trial prompted industry backlash.
Write your reply
Reposted by Richard E. Lenski
Doing science in the US is starting to feel untenable. The CDC has had no stable leader. RFK Jr broke his promises on vaccines & research. Climate change is denied. Moderna will no longer invest in late stage vaccine trials. Europe and China are seizing the moment.
🧪 bit.ly/3ZF0yzI
🧪 bit.ly/3ZF0yzI
Brain drain is undermining America’s scientific edge
Policy decisions grounded in Maga talking points are helping to fuel a PhD exodus from government
www.ft.com
February 19, 2026 at 12:56 AM
Doing science in the US is starting to feel untenable. The CDC has had no stable leader. RFK Jr broke his promises on vaccines & research. Climate change is denied. Moderna will no longer invest in late stage vaccine trials. Europe and China are seizing the moment.
🧪 bit.ly/3ZF0yzI
🧪 bit.ly/3ZF0yzI
But RFK and the other idiots who have taken over the CDC, FDA, and HHS would prefer to see that 50% be hospitalized and/or killed.
Brilliant plan. Ignorance and blind ideology kills.
Brilliant plan. Ignorance and blind ideology kills.
In people age 50+, the Covid booster halved hospitalization and deaths.
Waning of benefit after 3-6 months
For the mRNA BA.1 booster vs no shot after initial vaccination
www.sciencedirect.com/science/arti...
Waning of benefit after 3-6 months
For the mRNA BA.1 booster vs no shot after initial vaccination
www.sciencedirect.com/science/arti...
February 18, 2026 at 11:41 PM
But RFK and the other idiots who have taken over the CDC, FDA, and HHS would prefer to see that 50% be hospitalized and/or killed.
Brilliant plan. Ignorance and blind ideology kills.
Brilliant plan. Ignorance and blind ideology kills.
"In an announcement Wednesday morning, Moderna said the FDA has now agreed to review its vaccine after the company held a formal (Type A) meeting with the FDA and proposed a change to the regulatory pathways used in the application."
weird
weird
February 18, 2026 at 8:54 PM
"In an announcement Wednesday morning, Moderna said the FDA has now agreed to review its vaccine after the company held a formal (Type A) meeting with the FDA and proposed a change to the regulatory pathways used in the application."
weird
weird
by Amir Attaran
LOL they revered their decision after one week. It’s TACO, health science version.
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
www.nytimes.com
February 18, 2026 at 8:04 PM
LOL they revered their decision after one week. It’s TACO, health science version.
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine www.nytimes.com/2026/02/18/h...
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
www.nytimes.com
February 18, 2026 at 7:21 PM
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine www.nytimes.com/2026/02/18/h...
Moderna says the FDA will consider its new flu shot after resolving a public dispute abcnews.com/Health/wireS...
Moderna says the FDA will consider its new flu shot after resolving a public dispute
Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all
abcnews.com
February 18, 2026 at 7:20 PM
Moderna says the FDA will consider its new flu shot after resolving a public dispute abcnews.com/Health/wireS...
Reposted by Rita Rubin
A CMS policy ended mandatory childhood vaccine reporting. Reduced surveillance, weakened recommendations, and increased reliance on shared decision making without clinical equipoise could accelerate declining vaccination rates, undermine outbreak response, and leave families without clear guidance.
A Physician’s Warning: Ending Federal Childhood Vaccine Reporting Puts Children and Communities at Risk
According to a Centers & Medicare and Medicaid Services letter dated December 30th, 2025, state health officials will no longer be required to report childhood vaccinations to the Centers for Medicare...
www.linkedin.com
February 18, 2026 at 6:14 PM
A CMS policy ended mandatory childhood vaccine reporting. Reduced surveillance, weakened recommendations, and increased reliance on shared decision making without clinical equipoise could accelerate declining vaccination rates, undermine outbreak response, and leave families without clear guidance.
Reposted by Robert C. Richards, Nicholas Birns
Good news. The FDA will review Moderna’s mRNA flu shot, mRNA-1010, after initially refusing the application. If approved, the vaccine could be available for the 2026-27 flu season.
FDA Reverses Course and Will Now Review Moderna’s Flu Shot
The company’s mRNA flu shot, if approved, could be available for the 2026-27 flu season.
www.wsj.com
February 18, 2026 at 4:34 PM
Good news. The FDA will review Moderna’s mRNA flu shot, mRNA-1010, after initially refusing the application. If approved, the vaccine could be available for the 2026-27 flu season.
Every day Republican death cult finds new ways to kill Americans - U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says flip.it/lR5vOz
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...
flip.it
February 18, 2026 at 4:21 PM
Every day Republican death cult finds new ways to kill Americans - U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says flip.it/lR5vOz
This morning, the FDA reversed course. It will now review Moderna's flu vaccine.
The FDA's decisions have become far less predictable, but one thing has been constant: vaccine head Vinay Prasad has always chosen the most attention-grabbing action he can.
www.statnews.com/2026/02/18/m...
The FDA's decisions have become far less predictable, but one thing has been constant: vaccine head Vinay Prasad has always chosen the most attention-grabbing action he can.
www.statnews.com/2026/02/18/m...
The FDA’s Moderna pirouette is one more sign of chaos at the agency
For drugmakers and vaccine developers, an FDA reversal on Moderna's flu vaccine is better than the alternative. But it is also another sign of agency chaos.
www.statnews.com
February 18, 2026 at 3:34 PM
This morning, the FDA reversed course. It will now review Moderna's flu vaccine.
The FDA's decisions have become far less predictable, but one thing has been constant: vaccine head Vinay Prasad has always chosen the most attention-grabbing action he can.
www.statnews.com/2026/02/18/m...
The FDA's decisions have become far less predictable, but one thing has been constant: vaccine head Vinay Prasad has always chosen the most attention-grabbing action he can.
www.statnews.com/2026/02/18/m...
Reposted by Simon Roux
After initially rejecting Moderna’s application for review, the FDA will now consider the mRNA flu shot
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
After initially rejecting Moderna’s application for review, the FDA will now consider the mRNA flu shot
www.scientificamerican.com
February 18, 2026 at 2:58 PM
After initially rejecting Moderna’s application for review, the FDA will now consider the mRNA flu shot
Reposted by Elizabeth Saunders, Paul Goldsmith-Pinkham
Breaking News: The FDA reversed its decision on Moderna’s mRNA flu vaccine and agreed to review it for possible approval, Moderna said.
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
nyti.ms
February 18, 2026 at 1:55 PM
Breaking News: The FDA reversed its decision on Moderna’s mRNA flu vaccine and agreed to review it for possible approval, Moderna said.
Reposted by Brendan Nyhan
#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. www.statnews.com/2026/02/18/f...
FDA reverses course, agrees to review Moderna’s flu vaccine
The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.
www.statnews.com
February 18, 2026 at 1:45 PM
#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. www.statnews.com/2026/02/18/f...